DEF 14AThe Ballot
Taysha Gene Therapies, Inc. files DEF 14A
Filed Oct 5, 2023 · 2y ago · Accession 0001193125-23-251065
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- DEF 14A
- Filing date
- Oct 5, 2023
- Report date
- Nov 15, 2023
- Document
- d529157ddef14a.htm
- Size
- 226 KB